Insights & Resources

Life sciences companies often overlook SOX in IPO prep. Discover how early action and targeted strategies can strengthen investor confidence.

J.P. Morgan's Q1 2025 biopharma and medtech reports reveal larger deals, global growth and financial strategies shaping the life sciences industry.

Discover how outsourcing in pharmaceutical manufacturing enhances quality, ensures compliance and mitigates risks in a rapidly evolving industry.

New York’s business interruption law introduced new stand-alone coverage opportunities, providing businesses options for tailored protection.

Administrative, physical, and technical safeguards are an essential element of HIPAA security and essential for protecting PHI and ePHI.

California’s landmark legislative package places unprecedented climate reporting requirements on public and private companies that do business in California.

Weaver’s professionals discuss common manual processes and activities with the greatest potential for automation.

Updates to Form PF were designed to assess systemic risk and bolster regulatory oversight in the growing hedge fund industry. Find out more.

Weaver helps you understand the digital infrastructure of systems, applications and databases that will support the performance and success of your digital transformation initiative.

Find out how your organization can create a culture that can drive the performance and success of your digital transformation initiative.

Weaver's continuing series provides insight on general concepts to keep in mind as you plan and prioritize your digital transformation journey.

The Institute for Internal Auditors (IIA) published its third annual OnRisk report: OnRisk – A Guide to Understanding, Aligning, and Optimizing Risk, which identifies and defines key risks, as perceived by boards, management, and chief audit executives.